Indian Equities Surge as Vinay Rajani Flags LT Finance and Sandur Manganese as Potential NearTerm Picks Westpac Faces A26 Million Penalty for Hardship Application Processing Delays Cramers Market Commentary Highlights Potential Opportunities Amid Shifting Sector Dynamics TrumpXi Summit Yields Soybean and Rare Earths Deals China Signals Tariff Reduction SP 500 Hits Fresh High as Tech Surge Offsets Energy Slide Bloom Energy Surges 12 on 26 Billion Partnership with European AI Infrastructure Firm Nebius Falcons Beyond Global FBYD Q1 2026 Earnings Negative EPS Weighs on Shares APOS Q1 2026 Earnings EPS Slightly Misses Estimates as FixedIncome Security Reacts SOHOO Q2 2025 Earnings Preferred Dividend Coverage Strengthens Amid Steady Hotel Operations SBCF Q1 2026 Earnings Strong EPS Beat Amid Modest Revenue Performance ASP Isotopes Inc ASPI Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge RPAY Q1 2026 Earnings NonGAAP EPS Beats Estimates Shares Edge Higher Twist Bioscience TWST Holds Steady Near Midpoint as Key Levels Define Trading Range SLM Corporation SLM Edges Lower as Traders Eye Support Levels NBT Bancorp NBTB Slips 105 Amid Cautious Trading Holds Above Key Support LendingClub Stock Edges Lower as Shares Test Key Technical Levels CHS Inc Preferred CHSCN Holds Gains in Quiet Session Airlines Face Potential Winter Capacity Reductions Amid Weakening Demand Signals LQDA Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Slightly Blackstone Senior Floating Rate 2027 Term Fund BSL Holds Steady at 1305 Key Levels in Focus Kodiak AI Inc KDK Slips 193 as Stock Tests Key Support Levels Senmiao Technology AIHS Edges Higher in a Tight Range Testing Resistance Near 124 VALE Faces Tepid Trading as Shares Hover Near Key Support Amid Mixed Commodity Signals Doximity Inc DOCS Holds Near Support After Modest Decline Biohaven BHVN Surges 12 on Strong Volume Testing Key Resistance Public Storage PSA Holds Steady Near 305 as Traders Eye Key Resistance Levels Fulcrum Therapeutics FULC Holds Steady Near Support Amid Biotech Sector Uncertainty